Kook S-Y, Jeong H, Kang M J, Park R, Shin H J, Han S-H, Son S M, Song H, Baik S H, Moon M, Yi E C, Hwang D, Mook-Jung I
Department of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
School of Interdisciplinary Bioscience and Bioengineering, Department of Chemical Engineering, POSTECH, Pohang, Korea.
Cell Death Differ. 2014 Oct;21(10):1575-87. doi: 10.1038/cdd.2014.67. Epub 2014 May 23.
Calbindin-D28k (CB), one of the major calcium-binding and buffering proteins, has a critical role in preventing a neuronal death as well as maintaining calcium homeostasis. Although marked reductions of CB expression have been observed in the brains of mice and humans with Alzheimer disease (AD), it is unknown whether these changes contribute to AD-related dysfunction. To determine the pathogenic importance of CB depletions in AD models, we crossed 5 familial AD mutations (5XFAD; Tg) mice with CB knock-out (CBKO) mice and generated a novel line CBKO·5XFAD (CBKOTg) mice. We first identified the change of signaling pathways and differentially expressed proteins globally by removing CB in Tg mice using mass spectrometry and antibody microarray. Immunohistochemistry showed that CBKOTg mice had significant neuronal loss in the subiculum area without changing the magnitude (number) of amyloid β-peptide (Aβ) plaques deposition and elicited significant apoptotic features and mitochondrial dysfunction compared with Tg mice. Moreover, CBKOTg mice reduced levels of phosphorylated mitogen-activated protein kinase (extracellular signal-regulated kinase) 1/2 and cAMP response element-binding protein at Ser-133 and synaptic molecules such as N-methyl-D-aspartate receptor 1 (NMDA receptor 1), NMDA receptor 2A, PSD-95 and synaptophysin in the subiculum compared with Tg mice. Importantly, this is the first experimental evidence that removal of CB from amyloid precursor protein/presenilin transgenic mice aggravates AD pathogenesis, suggesting that CB has a critical role in AD pathogenesis.
钙结合蛋白-D28k(CB)是主要的钙结合和缓冲蛋白之一,在预防神经元死亡以及维持钙稳态方面起着关键作用。尽管在患有阿尔茨海默病(AD)的小鼠和人类大脑中已观察到CB表达显著降低,但尚不清楚这些变化是否导致与AD相关的功能障碍。为了确定AD模型中CB缺失的致病重要性,我们将5种家族性AD突变(5XFAD;Tg)小鼠与CB基因敲除(CBKO)小鼠杂交,培育出一种新的品系CBKO·5XFAD(CBKOTg)小鼠。我们首先通过质谱分析和抗体微阵列技术去除Tg小鼠中的CB,从而全面鉴定信号通路的变化和差异表达的蛋白质。免疫组织化学显示,与Tg小鼠相比,CBKOTg小鼠在海马下托区域有明显的神经元丢失,而淀粉样β肽(Aβ)斑块沉积的数量没有改变,并且出现了明显的凋亡特征和线粒体功能障碍。此外,与Tg小鼠相比,CBKOTg小鼠海马下托中磷酸化丝裂原活化蛋白激酶(细胞外信号调节激酶)1/2和cAMP反应元件结合蛋白在Ser-133位点的水平降低,以及突触分子如N-甲基-D-天冬氨酸受体1(NMDA受体1)、NMDA受体2A、PSD-95和突触素的水平也降低。重要的是,这是首个实验证据表明从淀粉样前体蛋白/早老素转基因小鼠中去除CB会加重AD发病机制,提示CB在AD发病机制中起关键作用。